CBRE Group, Inc. (CBRE)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	38,104	35,767	31,949	30,828	27,746	23,826
Revenue Growth (YoY)	14.96%	11.95%	3.64%	11.11%	16.45%	-0.28%
Cost of Revenue	30,686	28,747	25,650	24,207	21,580	19,006
Gross Profit	7,418	7,020	6,299	6,621	6,166	4,821
Selling, General & Admin	5,061	4,896	4,505	4,599	4,074	3,193
Operating Expenses	5,775	5,570	5,118	5,204	4,600	3,674
Operating Income	1,643	1,450	1,181	1,417	1,566	1,146
Interest Expense	-224	-215	-149	-69	-50	-67.75
Earnings From Equity Investments	52	-19	248	229	619	126.16
Other Non Operating Income (Expenses)	31	39	27	-12	-25	-
EBT Excluding Unusual Items	1,502	1,255	1,307	1,565	2,110	1,205
Merger & Restructuring Charges	-179	-179	-91	-100	-	-175.79
Impairment of Goodwill	-	-	-	-26	-	-25
Gain (Loss) on Sale of Investments	-	-	34	-	42	17.39
Gain (Loss) on Sale of Assets	148	142	27	244	258	87.79
Asset Writedown	-	-	-	-23	-	-63.68
Other Unusual Items	-2	-	-	-2	-	-75.59
Pretax Income	1,469	1,218	1,277	1,658	2,410	969.97
Income Tax Expense	292	182	250	234	568	214.1
Earnings From Continuing Operations	1,177	1,036	1,027	1,424	1,842	755.87
Minority Interest in Earnings	-87	-68	-41	-17	-5	-3.88
Net Income	1,090	968	986	1,407	1,837	751.99
Net Income to Common	1,090	968	986	1,407	1,837	751.99
Net Income Growth	17.96%	-1.83%	-29.92%	-23.41%	144.28%	-41.36%
Shares Outstanding (Basic)	302	306	308	323	335	335
Shares Outstanding (Diluted)	305	308	313	328	340	338
Shares Change (YoY)	-1.50%	-1.44%	-4.62%	-3.54%	0.39%	-0.63%
EPS (Basic)	3.61	3.16	3.20	4.36	5.48	2.24
EPS (Diluted)	3.57	3.14	3.15	4.29	5.41	2.22
EPS Growth	19.77%	-0.32%	-26.57%	-20.70%	143.69%	-41.11%
Free Cash Flow	1,114	1,401	175	1,369	2,154	1,564
Free Cash Flow Per Share	3.66	4.55	0.56	4.18	6.34	4.62
Gross Margin	19.47%	19.63%	19.72%	21.48%	22.22%	20.23%
Operating Margin	4.31%	4.05%	3.70%	4.60%	5.64%	4.81%
Profit Margin	2.86%	2.71%	3.09%	4.56%	6.62%	3.16%
Free Cash Flow Margin	2.92%	3.92%	0.55%	4.44%	7.76%	6.57%
EBITDA	2,395	2,151	1,828	2,030	2,092	1,627
EBITDA Margin	6.29%	6.01%	5.72%	6.59%	7.54%	6.83%
D&A For EBITDA	752	701	647	613	526	481.04
EBIT	1,643	1,450	1,181	1,417	1,566	1,146
EBIT Margin	4.31%	4.05%	3.70%	4.60%	5.64%	4.81%
Effective Tax Rate	19.88%	14.94%	19.58%	14.11%	23.57%	22.07%
Advertising Expenses	-	82	74	85	68.9	57.2

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q